🧪 TrialInsufficient
A Study in People With Overweight or Obesity to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body
Registered Phase 1 interventional trial (recruiting). The primary objective of this trial is to assess bioequivalence of two formulations of survodutide (formulation A and formulation B6) after multiple-dose treatment in male and female trial participants living with overweight or obesity.
ClinicalTrials.gov · Feb 2026View trial ↗